CIBC World Markets’s CorMedix CRMD Stock Holding History

CIBC World Markets’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,451	Closed	-$82.9K	–	1643
2025 Q1	$82.9K	Buy	+13,451	New	+$139K	﹤0.01%	1637

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

GCM

Ghisallo Capital Management Boston, Massachusetts $5.1B AUM 39.13% 1-Year Est. Return

CIBC World Markets's CRMD Position: Q2 2025 in Review

CIBC World Markets sold out of CorMedix (CRMD) in Q2 2025, closing a stake of 13,451 shares — an estimated $82.9K sold.

CIBC World Markets first reported a position in CRMD in Q1 2025 and held it in 1 quarter. The position peaked at $82.9K in Q1 2025. 172 funds tracked by Wall St. Rank hold CRMD as of Q2 2025.

CIBC World Markets reported no remaining CorMedix position as of Q2 2025 after selling out during the quarter.
CIBC World Markets sold 13,451 CorMedix shares in Q2 2025, an estimated $82.9K.
CIBC World Markets first reported a position in CorMedix in Q1 2025 and held it in 1 quarter.
CIBC World Markets's CorMedix position peaked at $82.9K in Q1 2025.
172 funds tracked by Wall St. Rank held CorMedix as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.